Rockefeller Capital Management
FRLN

Rockefeller Capital Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Rockefeller Capital Management’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-38
Closed – – 4084
2022
Q4 		$0 Hold
38
– – ﹤0.01% 4317
2022
Q3 		$0 Hold
38
– – ﹤0.01% 4508
2022
Q2 		$0 Buy
+38
New +$489 ﹤0.01% 4474

Other funds holding FRLN

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return

Rockefeller Capital Management's FRLN Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2023, closing a stake of 38 shares.

Rockefeller Capital Management first reported a position in FRLN in Q2 2022 and held it in 3 quarters. The position peaked at $0 in Q4 2022. 15 funds tracked by Wall St. Rank hold FRLN as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 38 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2023.
  • Rockefeller Capital Management first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q2 2022 and held it in 3 quarters.
  • Rockefeller Capital Management's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $0 in Q4 2022.
  • 15 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.